As mentioned earlier, cardiomyocytes do not express S100B in normal physiological conditions; however, S100B becomes expressed in cardiomyocytes surviving an infarction under the action of catecholamines and acts to inhibit the cardiomyocyte hypertrophic response with a mechanism that remains to be elucidated [13–15]. The gene discussed is S100B; the disease is infarction.